810 likes | 1.15k Views
Mark Upfal, MD, MPH Detroit Medical Center Emergency Medicine Grand Rounds Detroit Receiving Hospital February 13, 2003. Smallpox Vaccination. Collaborators: Kay Cadwell, Pat Goins, Kathy Reilly. Topics. Smallpox vaccination & history Vaccine effectiveness Administration/Outcomes
E N D
Mark Upfal, MD, MPH Detroit Medical Center Emergency Medicine Grand Rounds Detroit Receiving Hospital February 13, 2003 Smallpox Vaccination Collaborators: Kay Cadwell, Pat Goins, Kathy Reilly
Topics • Smallpox vaccination & history • Vaccine effectiveness • Administration/Outcomes • Revaccination
Topics • Adverse Reactions • Treatment • Contraindications
Topics • Smallpox & Vaccination History
Historic Timetable 1796 Dr. Jenner infects James Phipps w/ cowpox 1805 Use of cows to produce vaccine 1940s Freeze-drying technology 1949 Last US case of smallpox 1965 Licensure of bifurcated needle 1971 Routine vaccination stopped in US 1975 Last case of V. major in Bangladesh 1977 Last case of V. minor in Somalia 1983 Vaccine withdrawn from civilian market
Topics • Smallpox vaccination & history • Vaccine effectiveness
Protects against orthopox viruses • ATB’s w/in 10 days • Post-exposure – effective if given w/in 4-5 days
Topics • Smallpox vaccination & history • Vaccine effectiveness • Administration/Outcomes
Administration • No alcohol or prep • Dip into vial & pick up droplet btwn needle prongs • Never vaccinated: 3 rapid punctures perpendicular to skin, induces trace blood after 15-20” • Previously vaccinated: 3 rapid punctures perpendicular to skin, induces trace blood after 15-20” • Wipe off w/ gauze; dispose waste as biohazard
Method of Administration Applied to the upper arm using a multiple-puncture technique with a bifurcated needle.
Major reaction • Vesicular or pustular lesion or palpable induration surrounding a central crust or ulcer • Indicates success Equivocal reaction May be technique failure & no immunity Repeat vaccination
Expected Outcome Pustular lesion 6-12 days Papules 3-5 days CDC recommends daily checks for HCWs Scab 13-21 days
Topics • Smallpox vaccination & history • Vaccine effectiveness • Administration/Outcomes • Revaccination
Revaccination • Those vaccinated in 1970’s may not be protected • May have fewer adverse reactions • Revaccinate researchers every 10 yrs if still working with the virus
Topics • Adverse Events
Smallpox Vaccination and Adverse Reactions Guidance for Clinicians January 24, 2003 / 52(Dispatch);1-29
Common Side Effects • Local pain (30%), itching (80%) & erythema • Malaise • Low grade fever • Regional lymphadenopathy
Adverse Events(1/800) • Autoinnoculation 529 per million • Generalized Vaccinia 242 per million • Eczema Vaccinatum 39 per million • Vaccinia necrosum 1.5 per million • Vaccinial Encephalitis 12 per million
Generalized Vaccinia • Generalized vesicular skin lesions w/o eczema Hx or other preexisting skin dz • Believed 2o to viremia w/ dermal seeding • Usually minor; Few signif. sequelae
Generalized vaccinia Child recovered without sequela
Eczema Vaccinatum • Patients w/ h/o eczema • Generalized dermal spread • Rarely mild cases present only scattered individual lesions
Eczema Vaccinatum • Can occur w/ inactive eczema • More severe in contacts • Contact almost always in household